Firm News: Drugs & Devices: Page 15

On Thursday, May 1, 2014, Ellen Relkin, Esq., a N.J. Certified Civil Trial Attorney of Weitz & Luxenberg P.C., will be presenting a Mass Tort Case Law Review as well as present on the DePuy Hip and Stryker Rejuvenate litigations at the Boardwalk annual convention. The program is sponsored by the New Jersey Association for…

The FDA has announced plans to commission a study of the corrosion that occurs in certain models of metal hip implants, saying more data is needed to safeguard patients. The devices in question —prosthetic hip joints that have modular junctions which provide more options at implantation but pose risks for excess mechanical motion causing fretting and…

A former Accutane user was awarded $9 million by a New Jersey jury against Hoffmann La-Roche Inc. and Roche Laboratories, subsidiaries of Roche Holding AG (ROG). The pharmaceutical companies are based in Nutley, N.J. The plaintiff, one of four in a combined trial, took Accutane for acne treatment from 1997-1998 when she was a teenager. …

Weitz & Luxenberg P.C. has announced that Ellen Relkin will serve as a presenter at the June 28, 2010 Mass Torts Judicial Forum in Philadelphia, Pennsylvania. Ms. Relkin will participate in a discussion on expert witness testimony and medical causation proofs in this one-day seminar that includes presentations from a number of leading mass-tort judges…

Weitz & Luxenberg P.C. would like to inform patients of a debilitating condition, postarthroscopic glenohumeral chondrolysis (PAGCL), which results in the permanent degeneration of shoulder cartilage. This devastating and painful process has been linked to a post-surgical treatment for shoulder pain that has been performed across the country. Pain pumps are used to manage post-operative…